Effect of Yishen Huoxue Decoction for patients with chronic renal failure differentiated as syndrome of qi deficiency of spleen and kidney
-
摘要: 目的 探讨益肾活血汤对慢性肾衰竭(CRF)脾肾气虚证患者血清转化生长因子-β1(TGF-β1)及骨形态发生蛋白-7(BMP-7)水平的影响。 方法 将120例CRF脾肾气虚证患者随机分为研究组和对照组,每组60例。对照组给予卡托普利片和肾衰宁胶囊治疗,研究组给予益肾活血汤治疗。比较2组患者治疗前后血清TGF-β1、BMP-7水平,中医证候评分以及临床疗效。 结果 研究组治疗后血清TGF-β1水平显著低于对照组(P<0.05), 血清BMP-7水平显著高于对照组(P<0.05)。研究组患者治疗后中医证候评分显著低于对照组(P<0.05)。研究组总有效率为80.00%, 显著高于对照组的56.67%(P<0.05)。治疗过程中,所有患者均未出现发热、过敏等不良反应。 结论 益肾活血汤治疗CRF脾肾气虚证患者安全、有效,能够降低患者血清TGF-β1水平,提高血清BMP-7水平,改善患者预后。Abstract: Objective To explore the effect of Yishen Huoxue Decoction on levels of serum transforming growth factor-β1(TGF-β1)and bone morphogenetic protein-7(BMP-7)in patients with chronic renal failure(CRF)differentiated as syndrome of qi deficiency of spleen and kidney. Methods Totally 120 patients with CRF differentiated as syndrome of qi deficiency of spleen and kidney were randomly divided into study group and control group, with 60 cases in each group. The control group was treated with captopril tablets and Shenshuaining Capsules, and the study group was treated with Yishen Huoxue Decoction. The levels of serum TGF-β1 and BMP-7, score of traditional Chinese medicine(TCM)syndrome and clinical efficacy were compared between the two groups before and after treatment. Results After treatment, the serum TGF-β1 level in the study group was significantly lower than that in the control group(P<0.05), while the serum BMP-7 level was significantly higher than that in the control group(P<0.05). After treatment, the score of TCM syndrome in the study group was significantly lower than that in the control group(P<0.05). The total effective rate of the study group was 80.00%, which was significantly higher than 56.67% of the control group(P<0.05). During the course of treatment, no patient had adverse reactions such as fever and allergy. Conclusion Yishen Huoxue Decoction is safe and effective in the treatment of patients with CRF differentiated as syndrome of qi deficiency of spleen and kidney, which can reduce the level of serum TGF-β1, increase the level of serum BMP-7, and improve the prognosis of patients.
-
-
杨帆, 贾泽会. 慢性肾衰病机演变及证治探讨[J]. 中国中医基础医学杂志, 2017, 23(7): 907-908 , 917.
李思. 老年终末期肾病伴肿瘤患者血液透析中医证型分布及骨代谢相关指标变化研究[J]. 中华肿瘤防治杂志, 2018, 25(S2): 83-84. 齐振强, 任鲁颖, 冯国庆, 等. 慢性肾功能衰竭中医临床研究进展[J]. 中华中医药学刊, 2016, 34(8): 2006-2009. 莫超, 史伟, 谢丽萍, 等. 原发性肾小球疾病中医证型与生化指标的相关性[J]. 中国老年学杂志, 2018, 38(23): 5758-5760. 王河宝, 孙悦, 曹征, 等. 慢性肾功能衰竭中医发病机理探讨[J]. 时珍国医国药, 2019, 30(1): 155-156. 于大君, 周群清, 徐曼, 等. 老年慢性肾脏病的中医认识刍议[J]. 中华中医药杂志, 2017, 32(12): 5493-5495. 雷蕾, 熊维建, 钟锦, 等. 《慢性肾衰竭中医诊疗指南》临床应用评价体会[J]. 中华中医药杂志, 2016, 31(9): 3617-3619. 国家食品药品监督管理局. 中药新药临床研究指导原则(试行)[S]. 北京: 中国医药科技出版社, 2000: 359-360. 陈司汉, 柳尧, 曾炎, 等. 肾康宁胶囊对显性糖尿病肾病脾肾气虚证病情进展的延缓作用[J]. 中国实验方剂学杂志, 2017, 23(10): 183-188. 张艳琴, 辛晓龙, 李文东, 等. 高通量血液透析对慢性肾衰患者钙磷代谢紊乱的疗效分析[J]. 实用临床医药杂志, 2016, 20(11): 179-180 , 184.
HEE LEE M I, CHOI E N, JEON Y J, et al. Possible role of transforming growth factor-β1and vascularendothelial growth factor in Fabry disease nephropathy[J]. International Journal of Molecular Medicine, 2012, 30(6): 1275-1280.
蒲晓东, 杨艳梅. 基于慢性肾衰的中医临床研究论肾主泄浊[J]. 中国中医基础医学杂志, 2018, 24(8): 1054-1055 , 1058.
杨波, 乔延恒, 赵岩茹, 等. 从十年文献分析探寻中医药诊治慢性肾衰竭病因病机[J]. 辽宁中医杂志, 2016, 43(1): 58-59. 胡天祥, 李茵, 黎创, 等. 从三焦论治慢性肾衰的理论探讨[J]. 中国中医基础医学杂志, 2019, 25(7): 898-900. 水光兴, 孙伟. 论中医肾脏病学的发展[J]. 中华中医药杂志, 2016, 31(3): 755-757. 韩海燕, 路建饶, 王新华. 肾衰方对CKD4期慢性肾衰患者肾功能及钙磷代谢的影响[J]. 辽宁中医杂志, 2017, 44(2): 312-315. 李建英, 于俊生. 于俊生运用对药治疗慢性肾衰经验[J]. 中华中医药杂志, 2016, 31(6): 2182-2184. 张兴坤, 张丽, 张宗礼. 张宗礼醒脾通三焦法治疗慢性肾功能衰竭经验[J]. 中国中医基础医学杂志, 2017, 23(5): 717-719. -
期刊类型引用(8)
1. 朱元. 隔姜灸联合穴位贴敷对脾肾气虚型慢性肾衰竭患者中医证候及炎症状态的影响. 新疆中医药. 2024(03): 46-49 . 百度学术
2. 刘晖,林妍,杜珍芳. 健脾化湿法治疗慢性肾衰竭患者的疗效及对血清TGF-β1、BMP-7的水平的影响. 辽宁中医杂志. 2023(02): 94-97 . 百度学术
3. 漆石平. 肾衰方辅治早中期慢性肾功能衰竭脾肾气虚型疗效观察. 实用中医药杂志. 2023(05): 959-961 . 百度学术
4. 李丹,胡乐. 参苓白术散合金匮肾气丸加减联合穴位贴敷治疗慢性肾衰竭脾肾气虚型临床研究. 实用中医药杂志. 2023(09): 1749-1751 . 百度学术
5. 顾勤根. 益肾活血汤治疗慢性肾脏病CKD 3~4期的疗效探讨. 系统医学. 2023(19): 41-44 . 百度学术
6. 陈启霞,王未娟,张淋丹. 丁香肉桂穴位贴敷对慢性肾衰竭患者恶心呕吐的影响. 临床合理用药杂志. 2022(31): 88-90 . 百度学术
7. 王继红. 益肾活血汤联合常规西药治疗慢性肾衰竭失代偿期患者的效果. 中国民康医学. 2022(24): 96-99 . 百度学术
8. 潘磊,陆健,丁芳萍. 益肾活血通关汤对前列腺增生患者尿流动力学及IPSS评分的影响. 药品评价. 2021(07): 415-417 . 百度学术
其他类型引用(5)
计量
- 文章访问数: 363
- HTML全文浏览量: 94
- PDF下载量: 9
- 被引次数: 13